Sunday, 26 June, 2022
TopicKiran Mazumdar Shaw

Topic: Kiran Mazumdar Shaw

Anil Ambani, Tendulkar among Indians who parked funds in offshore firms, ‘Pandora Papers’ reveal

Tenzin Zompa -
The investigation is based on nearly 12 million documents obtained by the International Consortium and Investigative Journalists. The list names several prominent Indians and world leaders.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Mohana Basu -
Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

Nirmala Sitharaman, Roshni Nadar, Kiran Mazumdar-Shaw in Forbes’ 100 most powerful women list

Unnati Sharma -
The Forbes list also features young world leaders such as Finland PM Sanna Marin and New Zealand PM Jacinda Ardern, who are steering the Covid fight.

Entrepreneurship not about making money but having purpose, says Kiran Mazumdar-Shaw

PTI -
Speaking to students of Delhi's government schools, Shaw talked about her journey as a businesswoman and said that one must always think about giving back to society.

In Covid quarantine, Netflix, Amazon Prime were my constant companions: Kiran Mazumdar Shaw

Kiran Mazumdar Shaw -
I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.

Biocon chief Kiran Mazumdar-Shaw tests positive for Covid-19

PTI -
The 67-year-old biotechnology veteran tweeted saying her symptoms are mild as of now, and that she hopes it stays that way.

Russia is not world’s first to develop Covid vaccine, says Kiran Mazumdar-Shaw

PTI -
Biocon co-founder Kiran Mazumdar-Shaw also questioned the launch of a vaccine prior to completion of Phase 3 trials, saying if it's acceptable to Russia, so be it.

30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab

Sandhya Ramesh -
The drug controller general of India (DCGI) had Saturday approved Biocon’s itolizumab for emergency, restricted use among severe Covid-19 patients.

Made-in-India Covid-19 vaccine could be ready in a year, says Biocon’s Kiran Mazumdar-Shaw

Rohini Swamy -
In an interview to ThePrint, Biocon co-founder Kiran Mazumdar-Shaw says India is ahead of other countries in flattening the Covid-19 curve.

We have protected lives, it’s time to protect livelihoods: Kiran Mazumdar-Shaw on lockdown 

Mohana Basu -
In conversation with ThePrint Editor-in-Chief Shekhar Gupta, Mazumdar-Shaw said India needs to get back to work after 3 May, when the lockdown ends.
12Page 1 of 2

On Camera

YourTurn

Opinion

Economy

Illustration: Ramandeep Kaur | ThePrint

Does breaking up big states boost economy? Data doesn’t back up hype, says Indian study

Nikhil Rampal -
The study by researchers at Indira Gandhi Institute of Development Research looked at economic impact of reorganising Uttar Pradesh, Madhya Pradesh, and Bihar in the year 2000.

Defence

The Indian Air Force logo | Commons

Almost 4,000 enrol for IAF’s Agnipath recruitment scheme on day 1 of online registrations

Raghav Bikhchandani -
These registrations pertain to the Indian Air Force's Agniveer Vayu programme. The online portal for the first phase was opened at 10 am Friday, and will close on 5 July.

National Interest

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Shekhar Gupta -
Modi govt's biggest flaw has been its disinclination to accept limitations of electoral majorities. This ruined land acquisition and farm reform, stalled labour codes.

Follow us

Copyright © 2022 Printline Media Pvt. Ltd. All rights reserved.

×